| { | |
| "term": "Adderall", | |
| "role": "concept", | |
| "parent_concepts": [ | |
| "Mixture" | |
| ], | |
| "layer": 4, | |
| "domain": "PhysicalWorld", | |
| "definition": "Adderall and Mydayis are\ntrade names for a combination drug containing four salts of\n&%Amphetamine. The mixture is composed of equal parts racemic\namphetamine and dextroamphetamine, which produces a (3:1) ratio\nbetween dextroamphetamine and levoamphetamine, the two enantiomers of\namphetamine. Both enantiomers are &%timulants, but differ enough to\ngive Adderall an effects profile distinct from those of racemic\namphetamine or dextroamphetamine, which are marketed as Evekeo\nand Dexedrine/Zenzedi, respectively. Adderall is used in the\ntreatment of attention deficit hyperactivity disorder (&%ADHD) and\nnarcolepsy. It is also used as an athletic performance enhancer,\ncognitive enhancer, appetite suppressant, and recreationally as an\naphrodisiac and euphoriant. It is a central nervous system (CNS)\nstimulant of the phenethylamine class.[from Wikipedia]", | |
| "definition_source": "SUMO", | |
| "aliases": [ | |
| "adderall" | |
| ], | |
| "wordnet": { | |
| "synsets": [ | |
| "adderall.n.01" | |
| ], | |
| "canonical_synset": "adderall.n.01", | |
| "lemmas": [ | |
| "adderall" | |
| ], | |
| "pos": "noun" | |
| }, | |
| "relationships": { | |
| "related": [], | |
| "antonyms": [], | |
| "has_part": [], | |
| "part_of": [] | |
| }, | |
| "safety_tags": { | |
| "risk_level": "low", | |
| "impacts": [], | |
| "treaty_relevant": false, | |
| "harness_relevant": false | |
| }, | |
| "training_hints": { | |
| "positive_examples": [], | |
| "negative_examples": [], | |
| "disambiguation": "", | |
| "seed_terms": [ | |
| "adderall" | |
| ] | |
| }, | |
| "is_category_lens": true, | |
| "child_count": 0 | |
| } |